NEW MJ NEWS

AbbVie to Present at the RBC Capital Markets Global Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present virtually at 3:50 p.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-rbc-capital-markets-global-healthcare-conference-301289262.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

IONIC Brands (IONC) Enters the Highly Desirable Edibles and Infused Products Category With Signing of Definitive Agreement to Acquire Zoots Premium Cannabis-Infused Edibles

IONIC BRANDS ACQUIRES ZOOTS PREMIUM CANNABIS-INFUSED EDIBLES INFUSED PRODUCTS AND EDIBLES ARE…

CLS Holdings USA, Inc. (CLSH) (CLSH.CN) Reports Fourth Quarter and Fiscal Year End 2019 Financial Results

CLS Holdings Reports Fourth Quarter and Fiscal Year End 2019 Financial Results…

$OXIS Receive FDA Allowance To Proceed With OXS-1550

Oxis Biotech – University of Minnesota Masonic Cancer Center Receive FDA Allowance…

Future Farm Technologies Inc. (FFRMF) Hires RwE In Preparation For Spin Off Of New Augmented Reality Cannabis Company

Future Farm Hires RwE In Preparation For Spin Off Of New Augmented…